Deutsche Bank’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $575K | Sell |
51,180
-10,473
| -17% | -$118K | ﹤0.01% | 2377 |
|
|
2025
Q1 | $282K | Sell |
61,653
-3,256
| -5% | -$14.9K | ﹤0.01% | 2763 |
|
|
2024
Q4 | $366K | Buy |
64,909
+23,214
| +56% | +$131K | ﹤0.01% | 2750 |
|
|
2024
Q3 | $202K | Buy |
41,695
+14,863
| +55% | +$71.9K | ﹤0.01% | 2879 |
|
|
2024
Q2 | $131K | Sell |
26,832
-4,675
| -15% | -$22.8K | ﹤0.01% | 2988 |
|
|
2024
Q1 | $418K | Buy |
31,507
+5,068
| +19% | +$67.3K | ﹤0.01% | 2403 |
|
|
2023
Q4 | $369K | Sell |
26,439
-1,266
| -5% | -$17.6K | ﹤0.01% | 2492 |
|
|
2023
Q3 | $367K | Buy |
27,705
+2,299
| +9% | +$30.5K | ﹤0.01% | 2346 |
|
|
2023
Q2 | $476K | Sell |
25,406
-12,651
| -33% | -$237K | ﹤0.01% | 2398 |
|
|
2023
Q1 | $549K | Buy |
38,057
+12,240
| +47% | +$177K | ﹤0.01% | 2438 |
|
|
2022
Q4 | $500K | Buy |
25,817
+5,387
| +26% | +$104K | ﹤0.01% | 2443 |
|
|
2022
Q3 | $702K | Buy |
20,430
+2,912
| +17% | +$100K | ﹤0.01% | 2184 |
|
|
2022
Q2 | $268K | Sell |
17,518
-3,219
| -16% | -$49.2K | ﹤0.01% | 2975 |
|
|
2022
Q1 | $474K | Buy |
20,737
+10,766
| +108% | +$246K | ﹤0.01% | 2767 |
|
|
2021
Q4 | $368K | Buy |
9,971
+510
| +5% | +$18.8K | ﹤0.01% | 3004 |
|
|
2021
Q3 | $444K | Buy |
+9,461
| New | +$444K | ﹤0.01% | 3105 |
|